Back

Recovered vs remission heart failure among patients with LVEF improvement in non-Ischaemic HFrEF

30 August 2026 (16:15 - 16:45)
Organised by: Logo
Congress Presentation Part of: Heart failure: diagnosis and therapy Heart Failure with Reduced Ejection Fraction (HFrEF) ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Takeru Nabeta

Kitasato University School of Medicine, Sagamihara (Japan)

4 More presentations in this session

Presentation thumbnail
Baseline characteristics of patients with HFrEF on dapagliflozin: final analysis of baseline data from the EVOLUTION-HF DEallEF study HFrEF cohort
Professor B. Assmus (Giessen, DE)
Abstract
Presentation thumbnail
Real-world barriers to long-term ARNI therapy in HFrEF: a one-year analysis of tolerability and dose achievement
Doctor M. Santos Silva (Aveiro, PT)
Abstract
Presentation thumbnail
GLP-1 receptor agonists added to guideline-directed medical therapy in heart failure with reduced ejection fraction: a propensity score-matched analysis
Doctor I. Chough (Stony Brook, US)
Abstract
Presentation thumbnail
Cardiopulmonary exercise testing following conduction system versus biventricular pacing in heart failure: a substudy of the PhysioSync-HF randomized trial
Doctor A. Silveira (Porto Alegre, BR)
Abstract

Access the full session

Session thumbnail
Heart failure: diagnosis and therapy

The Event

Event poster

ESC Congress 2026

30 August 2026 16:15 CET
You may be interested in
thumbnail
Congress Presentation
Heart failure with improved left ventricular ejection fraction: impact in clinical outcomes.
29 June 2021
thumbnail
Congress Presentation
Myocardial remodelling and left ventricular recovery after guideline-directed medical therapy in non-ischaemic dilated cardiomyopathy
12 December 2024
thumbnail
Congress Presentation
Heart failure stage regression within a population based community
22 May 2023
thumbnail
Congress Presentation
Left ventricular non-compaction cardiomyopathy: predictors of heart failure progression requiring hospitalization
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources